Vaccinations reduce the risk of COVID death in India by 0.4 percent
Vaccinations reduce the risk of COVID death in India by 0.4 percent
admin
New Delhi: Vaccines aimed at reducing COVID-19 deaths and hospitalizations in patients, particularly those infected with the highly transmissible delta form that wreaked havoc in India's second wave, are currently being tested from Los Angeles to Melbourne.
According to a new study led by Nivedita Gupta of the Indian Council of Medical Research (ICMR), roughly 0.4 percent of people who were ill after getting vaccinated died, while over 10% needed hospitalisation.
According to Bloomberg, the study studied genome sequencing data from 677 COVID patients and discovered that the delta mutation was responsible for 86% of fully-inoculated cases.
The study concluded, "This obviously shows that vaccination decreases illness severity, hospitalisation, and mortality."
“Therefore, enhancing the vaccination drive and immunizing the populations quickly would be the most important strategy to prevent further deadly waves of the Covid-19 and would reduce the burden on the health care system,” the study further revealed.
592 participants had both jabs, while 85 had only one, according to the study, which is still being peer-reviewed. India has utilised AstraZeneca Plc's Covishield, a classical vector-based vaccine whose efficacy against the delta variant has been questioned in comparison to Pfizer Inc.'s and Moderna Inc.'s extremely effective messenger RNA vaccines.
